Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Quick Ratio 2011-2025 | EVO

Historical quick ratio values for Evotec AG (EVO) over the last 10 years.
Evotec AG Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-09-30 $0.89B $0.44B 2.04
2025-06-30 $0.65B $0.44B 1.49
2025-03-31 $0.73B $0.38B 1.93
2024-12-31 $0.70B $0.37B 1.89
2024-09-30 $0.73B $0.37B 1.99
2024-06-30 $0.67B $0.39B 1.73
2024-03-31 $0.86B $0.48B 1.79
2023-09-30 $0.99B $0.47B 2.09
2023-06-30 $1.08B $0.53B 2.04
2022-12-31 $1.10B $0.36B 3.09
2022-09-30 $1.07B $0.34B 3.13
2022-06-30 $1.19B $0.34B 3.48
2022-03-31 $1.16B $0.38B 3.05
2021-12-31 $1.27B $0.38B 3.31
2021-09-30 $0.71B $0.30B 2.39
2021-06-30 $0.74B $0.30B 2.50
2021-03-31 $0.80B $0.29B 2.78
2020-12-31 $0.74B $0.24B 3.10
2020-09-30 $0.49B $0.23B 2.13
2020-06-30 $0.48B $0.20B 2.40
2020-03-31 $0.50B $0.20B 2.45
2019-12-31 $0.51B $0.20B 2.56
2019-09-30 $0.44B $0.15B 2.97
2019-06-30 $0.51B $0.16B 3.19
2019-03-31 $0.28B $0.21B 1.33
2018-12-31 $0.29B $0.23B 1.24
2018-09-30 $0.31B $0.27B 1.13
2018-06-30 $0.24B $0.27B 0.90
2018-03-31 $0.21B $0.30B 0.70
2017-12-31 $0.19B $0.28B 0.70
2017-09-30 $0.20B $0.32B 0.64
2017-06-30 $0.25B $0.05B 4.88
2017-03-31 $0.24B $0.05B 5.11
2016-12-31 $0.18B $0.08B 2.25
2016-09-30 $0.17B $0.05B 3.65
2016-06-30 $0.17B $0.05B 3.35
2016-03-31 $0.17B $0.05B 3.16
2015-12-31 $0.18B $0.06B 2.90
2015-09-30 $0.19B $0.07B 2.69
2015-06-30 $0.19B $0.07B 2.58
2015-03-31 $0.14B $0.04B 3.90
2014-12-31 $0.16B $0.04B 3.70
2014-09-30 $0.15B $0.04B 3.51
2014-06-30 $0.15B $0.04B 3.51
2014-03-31 $0.16B $0.05B 3.29
2013-12-31 $0.16B $0.05B 3.09
2013-09-30 $0.15B $0.04B 3.48
2013-06-30 $0.10B $0.04B 2.38
2013-03-31 $0.11B $0.05B 2.34
2012-12-31 $0.11B $0.04B 2.53
2012-09-30 $0.10B $0.05B 1.97
2012-06-30 $0.09B $0.04B 2.08
2012-03-31 $0.10B $0.05B 1.96
2011-12-31 $0.11B $0.06B 1.86
2011-09-30 $0.10B $0.05B 1.97
2011-06-30 $0.10B $0.05B 1.82
2011-03-31 $0.11B $0.04B 2.57
2010-12-31 $0.00B $0.02B 0.00
2010-09-30 $0.10B $0.04B 2.81
2010-06-30 $0.10B $0.03B 3.06
2010-03-31 $0.09B $0.03B 2.65
2009-12-31 $0.09B $0.04B 2.52
2009-09-30 $0.09B $0.03B 2.89
2009-06-30 $0.10B $0.03B 3.18
2009-03-31 $0.12B $0.04B 3.10
2008-12-31 $0.13B $0.03B 4.17
2008-09-30 $0.15B $0.03B 5.18
2008-06-30 $0.16B $0.03B 4.77
2008-03-31 $0.13B $0.03B 4.85
2007-12-31 $0.15B $0.03B 4.50
2007-09-30 $0.11B $0.03B 3.23
2007-06-30 $0.13B $0.04B 3.24
2007-03-31 $0.11B $0.03B 3.16
2006-12-31 $0.11B $0.06B 1.85
2006-09-30 $0.10B $0.04B 2.78
2006-06-30 $0.10B $0.04B 2.71
2006-03-31 $0.07B $0.04B 1.96
2005-12-31 $0.09B $0.04B 2.41
2005-09-30 $0.09B $0.04B 2.38
2005-06-30 $0.10B $0.04B 2.75
2005-03-31 $0.04B $0.03B 1.30
2004-12-31 $0.04B $0.03B 1.67
2004-09-30 $0.04B $0.02B 1.55
2004-06-30 $0.03B $0.03B 1.34
2004-03-31 $0.04B $0.03B 1.49
2003-12-31 $0.04B $0.03B 1.46
2003-09-30 $0.04B $0.03B 1.57
2003-06-30 $0.04B $0.03B 1.43
2003-03-31 $0.04B $0.02B 1.71
2002-12-31 $0.04B $0.02B 1.75
2002-09-30 $0.03B $0.02B 1.57
2002-06-30 $0.03B $0.02B 1.84
2002-03-31 $0.04B $0.02B 2.16
2001-12-31 $0.04B $0.02B 2.11
2001-09-30 $0.04B $0.01B 2.62
2001-06-30 $0.04B $0.02B 2.70
2001-03-31 $0.06B $0.02B 2.90
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.052B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.154B 33.86
Zoetis (ZTS) United States $52.354B 18.74
Takeda Pharmaceutical (TAK) Japan $44.993B 9.18
BeOne Medicines - (ONC) Switzerland $44.644B 218.97
Daiichi Sankyo, - (DSNKY) Japan $41.960B 20.90
Sandoz Group AG (SDZNY) Switzerland $30.210B 0.00
United Therapeutics (UTHR) United States $20.319B 17.88
Merck (MKKGY) Germany $17.344B 10.69
Shionogi (SGIOY) Japan $14.581B 13.39
Neurocrine Biosciences (NBIX) United States $14.314B 34.34
Summit Therapeutics (SMMT) United States $13.071B 0.00
IPSEN (IPSEY) France $12.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.569B 0.00
Ionis Pharmaceuticals (IONS) United States $11.866B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.668B 0.00
Corcept Therapeutics (CORT) United States $7.902B 85.36
Stevanato Group S.p.A (STVN) Italy $6.514B 36.46
Grifols, S.A (GRFS) Spain $5.844B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.372B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.640B 17.28
Hypermarcas (HYPMY) Brazil $3.072B 21.09
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Dyne Therapeutics (DYN) United States $2.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 8.85
Soleno Therapeutics (SLNO) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.533B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.248B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.042B 24.20
Guardian Pharmacy Services (GRDN) United States $1.794B 34.55
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Harrow (HROW) United States $1.492B 91.57
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.436B 0.00
Collegium Pharmaceutical (COLL) United States $1.433B 7.10
Oruka Therapeutics (ORKA) United States $1.367B 0.00
Enliven Therapeutics (ELVN) United States $1.291B 0.00
Nektar Therapeutics (NKTR) United States $1.212B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Relay Therapeutics (RLAY) United States $1.147B 0.00
Xencor (XNCR) United States $1.115B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Theravance Biopharma (TBPH) United States $0.914B 38.38
Savara (SVRA) United States $0.855B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.772B 6.89
Organogenesis (ORGO) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.751B 0.00
ARS Pharmaceuticals (SPRY) United States $0.724B 0.00
Aquestive Therapeutics (AQST) United States $0.710B 0.00
Lexeo Therapeutics (LXEO) United States $0.692B 0.00
Esperion Therapeutics (ESPR) United States $0.674B 0.00
ProKidney (PROK) United States $0.662B 0.00
4D Molecular Therapeutics (FDMT) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.624B 0.00
Bioventus (BVS) United States $0.584B 11.97
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.508B 12.04
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Altimmune (ALT) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.423B 5.78
Galectin Therapeutics (GALT) United States $0.387B 0.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 21.39
USANA Health Sciences (USNA) United States $0.346B 9.65
Silence Therapeutics (SLN) United Kingdom $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Larimar Therapeutics (LRMR) United States $0.292B 0.00
Pyxis Oncology (PYXS) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
Achieve Life Sciences (ACHV) Canada $0.234B 0.00
OmniAb (OABI) United States $0.219B 0.00
Protara Therapeutics (TARA) United States $0.215B 0.00
AleAnna (ANNA) United States $0.211B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Relmada Therapeutics (RLMD) United States $0.132B 0.00
Unicycive Therapeutics (UNCY) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.118B 0.00
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Prelude Therapeutics (PRLD) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.099B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
VAXART, INC (VXRT) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.75
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Acrivon Therapeutics (ACRV) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Fractyl Health (GUTS) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.070B 0.00
Plus Therapeutics (PSTV) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Talphera (TLPH) United States $0.062B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Wellgistics Health (WGRX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Liminatus Pharma (LIMN) United States $0.029B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.028B 23.75
Vyome Holdings (HIND) United States $0.028B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Inotiv (NOTV) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00